Foam sclerotherapy: Investigating the need for sterile air

Dermatologic Surgery

Volumn 37, Issue 8, 2011, Pages 1119-1124

  De Roos, Kees Peter ^a   Groen, Leon ^b   Leenders, Alexander C A P ^c  

^a DermaPark ^*  (Netherlands)

^b BERNHOVEN HOSPITAL   (Netherlands)

^c JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLIDOCANOL;

AIR QUALITY; AMBIENT AIR; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; GROWTH INHIBITION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCLEROTHERAPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PYOGENES;

AIR MICROBIOLOGY; BACTERIAL INFECTIONS; COLONY COUNT, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYETHYLENE GLYCOLS; PSEUDOMONAS AERUGINOSA; SCLEROSING SOLUTIONS; SCLEROTHERAPY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STERILIZATION; STREPTOCOCCUS PYOGENES; VARICOSE VEINS;

EID: 80053601247     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2011.02044.x     Document Type: Article

References (17)

1. Feied C., Sclerosing solutions. In:, Bergan JJ, editor. The Vein Book. New York: Elsevier; 2007. p. 125-38.
2. Gillet J-L, Guedes JM, Guex J-J, Hamel-Desnos C, et al,. Side-effects and complications of foam sclerotherapy of the great and small saphenous veins: a controlled multicentre prospective study including 1,025 patients. Phlebology 2009; 24: 131-8.
3. Cabrera J, Cabrera J Jr., Garcia-Olmedo MA., Sclerosants in microfoam. A new approach in angiology. Int Angiol 2001; 20: 322-9. (Pubitemid 34232881)
4. Tessari L., Nouvelle technique d'obtention de la scléromousse. Phlébologie 2000; 53: 129-35 [no English abstract available].
5. Frullini A., A new technique in producing sclerosing foam in a disposable syringe. Dermatol Surg 2000; 26: 705-6. (Pubitemid 30470644)
6. Tessari L, Cavezzi A, Frullini A., Preliminary experience with a new sclerosing foam in the treatment of Varicose Veins. Dermatol Surg 2001; 27: 58-60. (Pubitemid 32107620)
7. Frullini A, Cavezzi A., Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 2002; 28: 11-5. (Pubitemid 34101573)
8. Wollmann J-C., The history of sclerosing foams. Dermatol Surg 2004; 30: 694-703. (Pubitemid 38657960)
9. Monfreux A., Traitement sclérosant des troncs saphènes et leurs collatérales de gros calibres par la méthode MUS. Phlébologie 1997; 50: 351-3. [no English abstract available].
10. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, et al,. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study". Eur J Vasc Endovasc Surg 2007; 34: 723-9. (Pubitemid 350056378)
11. Breu FX, Guggenbichler S, Wollmann J-C., 2nd European Consensus Meeting on Foam Sclerotherapy 2006 Tegernsee, Germany. VASA 2008; 37 (suppl 71): 1-29.
12. Sadick NS, Senterfit LB, Klein RF., The intrinsic antimicrobial activity of selected sclerosing agents in sclerotherapy. Dermatol Surg 1996; 22: 369-71. (Pubitemid 26144662)
13. Dutch Working Party on Infection Prevention (WIP). Circumstances during (minor) surgical and invasive procedures. April 2006. Available from:.
14. ™ operating Manual. Germany: Dreieich; 2004.
15. Jia X, Mowatt G, Burr JM, Cassar K, et al,. Systemic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-36. (Pubitemid 47236534)
16. Natali J, Farman T., Implications medico-légales au cours du traitement sclérothérapeutique des varices. J Mal Vasc 1996; 21: 227-32. [no English abstract available]. (Pubitemid 26395610)
17. Guex J-J, Allaert F-A, Gillet J-L, Chleir F., Immediate and midterm complications of sclerotherapy. Report of a prospective multicenter registry of 12,173 sclerotherapy sessions. Dermatol Surg 2005; 31: 123-8. (Pubitemid 40990934)